Purchase Order 75N95019P00194

Award Date 2/28/19
Potential Completion Date 2/28/22
Potential Value $83K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $71,550 sole source purchase order contract to Altoris, Inc. for a 1-year subscription and two 1-year option periods to renew the SARvision SM software license. Altoris, Inc. is the only vendor that can provide the required proprietary SARvision SM software to support NCATS' translational sciences programs. The contract includes a base year from September 15, 2023 through September...
This firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Nextmove Software LIMITED, a for-profit software company based in the United Kingdom. The $42,800 contract is for annual software licenses, maintenance, and perpetual licenses for Nextmove's HazELNut, LeadMine, CaffeineFix, SmallWorld, and Pistachio software products. These solutions...
This firm-fixed price purchase order, valued at $19,798.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to the foreign-owned, for-profit company Andor Technology, Inc. The contract is for the annual renewal of an Imaris software license, which is an essential tool used by NCATS to analyze fluorescence microscopy data and support its ongoing research projects related to stem cell technology. The...
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $15,300 purchase order to Chemical Computing Group ULC for annual software licenses of the Molecular Operating Environment without scientific support. The solicitation sought the molecular modeling software to enable various drug design applications across multiple operating systems and hardware for use at the National Center for Advancing Translational...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $26,870 sole-source purchase order to Caerus US 1 Inc., operating as Citeline, to provide five one-year licenses for its Biomedtracker database and five one-year licenses for the Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a comprehensive...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,634.80 firm-fixed-price purchase order to National Instruments Corporation for a one-year renewal of a proprietary system design software license subscription. The original sole-source solicitation sought a 12-month license for software to perform custom algorithmic analysis of images from high-content screening devices and compound plate quality control,...
This is a firm fixed price purchase order award from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Virscidian Inc., a for-profit software company, for the Virscidian Analytical Studio Express - Instrument Agent software package. The $97,106.08 award has a completion date of August 31, 2020 and is a non-competitive sole source contract with no set-aside designation. The solicitation was specifically for this software package, which provides...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services National Institutes of Health, to Inte:ligand Software-Entwicklungs- UND Consulting GmbH, an Austrian company. The $25,990.00 contract is for the one-year renewal of licenses to the company's LigandScout software suite, which provides molecular modeling and drug discovery informatics tools to support NCATS' translational...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences (NIEHS) awarded a $222,000.00 Firm Fixed Price Purchase Order contract to Causaly LTD, a for-profit organization based in the United Kingdom. The contract is for the acquisition of a licensing right to use Causaly LTD's proprietary software platform, which utilizes natural language processing and artificial intelligence to discover biomedical knowledge from sources such...

This is a $82,823.54 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the National Institutes of Health (NIH), to Cresset Biomolecular Discovery LIMITED, a for-profit organization based in the United Kingdom. The contract is for a software license for 5 users to aid NCATS' chemists with 3D structure-activity relationship (SAR) analysis, generation of novel and diverse molecular structures using bioisosteres, and understanding SAR and design. The contract has a base period of performance from March 1, 2019 to February 29, 2020, with two 1-year option periods. There was no set-aside used for this award.

Generated 4/1/25, 8:11 PM